Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06876168 · ClinicalTrials.gov registry record
Virtual Reality in ICU - PARTNER
A clinical trial of Sepsis and Acute Respiratory Failure, sponsored by Kirby Mayer.
- Recruiting
- Registry status
- 32
- Enrollment target
- 1
- Study location
NCT06876168: Recruiting study of Sepsis and Acute Respiratory Failure, sponsored by Kirby Mayer.
NCT06876168 is a study of Sepsis and Acute Respiratory Failure that is actively recruiting participants, run by Kirby Mayer. The registered enrollment target is 32 participants, below the 6,564-participant average among 90 other Sepsis trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06876168, a study of Sepsis and Acute Respiratory Failure, is actively recruiting participants, sponsored by Kirby Mayer.
- RECRUITING
- Registry status
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
This project is designed to have patients participate in a virtual environment with various tasks such as breathing exercises, games to help the brain, and techniques that promote relaxation while hospitalized in the Intensive Care Unit (ICU). The participation in research will last about 5 days and take about 15 to 45 minutes each day.
Primary Outcome
System Usability Scale - describing the ease of use of the procedure and device
Conditions Studied
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2025-07-02 |
| Est. Completion | 2026-09-30 |
What NCT06876168 shows while recruiting
NCT06876168 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 6,564-participant average among 90 other Sepsis trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Sepsis appearing as the primary indexed condition, and to 0 interventions.
NCT06876168 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT06876168 about?
NCT06876168 is a clinical study titled "Virtual Reality in ICU - PARTNER". This project is designed to have patients participate in a virtual environment with various tasks such as breathing exercises, games to help the brain, and techniques that promote relaxation while hospitalized in the Intensive Care Unit (ICU). The participation in research will last about 5 days and...
What is the current status of trial NCT06876168?
This trial is currently recruiting. The enrollment target is 32 participants. The study started on 2025-07-02. Estimated completion is 2026-09-30.
What conditions does trial NCT06876168 study?
This clinical trial studies the following conditions: Sepsis, Acute Respiratory Failure.
Who is sponsoring clinical trial NCT06876168?
This trial is sponsored by Kirby Mayer, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06876168 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06876168's enrollment target sits among peer trials
32 80th of 90 higher than 11 of 90 other Sepsis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sepsis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The APS Phenotyping Study
RECRUITING
-
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
RECRUITING · Phase 2
-
Early Versus Late Adjunctive Vasopressin in Septic Shock
RECRUITING · Phase 4
-
Renin Angiotensin Aldosterone System In Septic Kids
RECRUITING
-
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
RECRUITING · NA
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI